These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

671 related items for PubMed ID: 28166203

  • 1. LncRNA HULC triggers autophagy via stabilizing Sirt1 and attenuates the chemosensitivity of HCC cells.
    Xiong H, Ni Z, He J, Jiang S, Li X, He J, Gong W, Zheng L, Chen S, Li B, Zhang N, Lyu X, Huang G, Chen B, Zhang Y, He F.
    Oncogene; 2017 Jun 22; 36(25):3528-3540. PubMed ID: 28166203
    [Abstract] [Full Text] [Related]

  • 2. lncRNA HULC promotes the growth of hepatocellular carcinoma cells via stabilizing COX-2 protein.
    Xiong H, Li B, He J, Zeng Y, Zhang Y, He F.
    Biochem Biophys Res Commun; 2017 Aug 26; 490(3):693-699. PubMed ID: 28634076
    [Abstract] [Full Text] [Related]

  • 3. Long noncoding RNA highly upregulated in liver cancer promotes the progression of hepatocellular carcinoma and attenuates the chemosensitivity of oxaliplatin by regulating miR-383-5p/vesicle-associated membrane protein-2 axis.
    Li P, Li Y, Ma L.
    Pharmacol Res Perspect; 2021 Aug 26; 9(4):e00815. PubMed ID: 34223709
    [Abstract] [Full Text] [Related]

  • 4. USP22 mediates the multidrug resistance of hepatocellular carcinoma via the SIRT1/AKT/MRP1 signaling pathway.
    Ling S, Li J, Shan Q, Dai H, Lu D, Wen X, Song P, Xie H, Zhou L, Liu J, Xu X, Zheng S.
    Mol Oncol; 2017 Jun 26; 11(6):682-695. PubMed ID: 28417539
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Long noncoding RNA HULC accelerates liver cancer by inhibiting PTEN via autophagy cooperation to miR15a.
    Xin X, Wu M, Meng Q, Wang C, Lu Y, Yang Y, Li X, Zheng Q, Pu H, Gui X, Li T, Li J, Jia S, Lu D.
    Mol Cancer; 2018 Jun 12; 17(1):94. PubMed ID: 29895332
    [Abstract] [Full Text] [Related]

  • 8. Metformin inhibits tumorigenesis in HBV-induced hepatocellular carcinoma by suppressing HULC overexpression caused by HBX.
    Jiang Z, Liu H.
    J Cell Biochem; 2018 Jun 12; 119(6):4482-4495. PubMed ID: 29231260
    [Abstract] [Full Text] [Related]

  • 9. Specificity protein (Sp) transcription factors and metformin regulate expression of the long non-coding RNA HULC.
    Gandhy SU, Imanirad P, Jin UH, Nair V, Hedrick E, Cheng Y, Corton JC, Kim K, Safe S.
    Oncotarget; 2015 Sep 22; 6(28):26359-72. PubMed ID: 26317792
    [Abstract] [Full Text] [Related]

  • 10. MiR-26 enhances chemosensitivity and promotes apoptosis of hepatocellular carcinoma cells through inhibiting autophagy.
    Jin F, Wang Y, Li M, Zhu Y, Liang H, Wang C, Wang F, Zhang CY, Zen K, Li L.
    Cell Death Dis; 2017 Jan 12; 8(1):e2540. PubMed ID: 28079894
    [Abstract] [Full Text] [Related]

  • 11. MicroRNA-125b reverses oxaliplatin resistance in hepatocellular carcinoma by negatively regulating EVA1A mediated autophagy.
    Ren WW, Li DD, Chen X, Li XL, He YP, Guo LH, Liu LN, Sun LP, Zhang XP.
    Cell Death Dis; 2018 May 01; 9(5):547. PubMed ID: 29749374
    [Abstract] [Full Text] [Related]

  • 12. LncRNA CASC2 inhibited the viability and induced the apoptosis of hepatocellular carcinoma cells through regulating miR-24-3p.
    Fan JC, Zeng F, Le YG, Xin L.
    J Cell Biochem; 2018 Aug 01; 119(8):6391-6397. PubMed ID: 29091305
    [Abstract] [Full Text] [Related]

  • 13. Liver X receptor inhibits the growth of hepatocellular carcinoma cells via regulating HULC/miR-134-5p/FOXM1 axis.
    He J, Yang T, He W, Jiang S, Zhong D, Xu Z, Wei Q, Zhang Y, Shi C.
    Cell Signal; 2020 Oct 01; 74():109720. PubMed ID: 32711110
    [Abstract] [Full Text] [Related]

  • 14. The long noncoding RNA HULC promotes liver cancer by increasing the expression of the HMGA2 oncogene via sequestration of the microRNA-186.
    Wang Y, Chen F, Zhao M, Yang Z, Li J, Zhang S, Zhang W, Ye L, Zhang X.
    J Biol Chem; 2017 Sep 15; 292(37):15395-15407. PubMed ID: 28765279
    [Abstract] [Full Text] [Related]

  • 15. Long noncoding RNA HULC modulates abnormal lipid metabolism in hepatoma cells through an miR-9-mediated RXRA signaling pathway.
    Cui M, Xiao Z, Wang Y, Zheng M, Song T, Cai X, Sun B, Ye L, Zhang X.
    Cancer Res; 2015 Mar 01; 75(5):846-57. PubMed ID: 25592151
    [Abstract] [Full Text] [Related]

  • 16. Long noncoding RNA HULC promotes hepatocellular carcinoma progression.
    Zhang H, Liao Z, Liu F, Su C, Zhu H, Li Y, Tao R, Liang H, Zhang B, Zhang X.
    Aging (Albany NY); 2019 Oct 23; 11(20):9111-9127. PubMed ID: 31645479
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of miR-15a-5p Promotes the Chemoresistance to Pirarubicin in Hepatocellular Carcinoma via Targeting eIF4E.
    Zhang Y, Tie Q, Bao Z, Shao Z, Zhang L.
    Comput Math Methods Med; 2021 Oct 23; 2021():6468405. PubMed ID: 34812269
    [Abstract] [Full Text] [Related]

  • 18. [LncRNA HULC promots HCC growth by downregulating miR-29].
    Zhu LR, Feng JL, Liu XJ, Wang JM.
    Zhonghua Zhong Liu Za Zhi; 2019 Sep 23; 41(9):659-666. PubMed ID: 31550855
    [Abstract] [Full Text] [Related]

  • 19. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker.
    Zhao X, Liu Y, Yu S.
    Biochim Biophys Acta Mol Basis Dis; 2017 Jul 23; 1863(7):1805-1816. PubMed ID: 28428004
    [Abstract] [Full Text] [Related]

  • 20. Upregulated miR-182 increases drug resistance in cisplatin-treated HCC cell by regulating TP53INP1.
    Qin J, Luo M, Qian H, Chen W.
    Gene; 2014 Apr 01; 538(2):342-7. PubMed ID: 24447717
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.